December 13, 2024 15:58 (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Bengaluru techie suicide: Karnataka Police issues summons to wife Nikita, her family members | French President Macron appoints centrist leader Francois Bayrou as new Prime Minister | Congress always prioritised personal interest over Constitution: Rajnath Singh | Jaishankar calls attack on Hindus in Bangladesh 'a source of concern' | Allu Arjun arrested over woman's death in stampede during Pushpa 2 premiere show | RBI receives bomb threat in Russian language, case filed | UP teenager kills mother, lives with body for 5 days | At least six people including a child killed in Tamil Nadu hospital fire | Amid Atul Subhash row, SC says mere harassment is not enough to prove abetment to suicide | India's D Gukesh becomes youngest ever world champion in chess

Over two-thirds people in Nepal have COVID-19 antibodies: Survey

Aug 30, 2021, at 11:10 pm

Kathmandu/UNI/XINHUA: Over two-thirds of Nepal's population has developed antibodies against COVID-19, as shown by a nationwide survey conducted by the Ministry of Health and Population (MoHP).

Antibodies to SARS-CoV-2 remain stable, or even increase, seven months after infection: Study

Aug 09, 2021, at 11:29 pm

Barcelona: The levels of IgG antibodies against SARS-CoV-2 Spike protein remain stable, or even increase, seven months after infection, according to a follow-up study in a cohort of healthcare workers coordinated by the Barcelona Institute for Global Health (ISGlobal), an institution supported by “la Caixa” Foundation, in collaboration with the Hospital Clinic of Barcelona.

Chinese Sinopharm COVID-19 vaccine falls short in producing antibodies: Study

Aug 06, 2021, at 06:29 am

Budapest: A Hungarian study has found China's Sinopharm vaccines failed to  produce sufficient antibodies in a quarter of elderly people who were voluntarily tested in Budapest, media reports said.

India's COVAXIN generates antibodies that effectively neutralize Alpha and Delta variants of coronavirus, says US health research institute

Jun 30, 2021, at 02:38 pm

Washington: A study conducted by  the US' National Institute of Health has said India's COVAXIN, which was developed by Bharat Biotech in collaboration with the Indian Council of Medical Research, neutralises both Alpha and Delta variants of COVID-19.

Another sero survey finds over 56 percent residents of Delhi have developed antibodies against Coronavirus

Feb 02, 2021, at 09:52 pm

New Delhi: A  fifth serological survey conducted in New Delhi has found that more than 56 percent of residents in Delhi have been exposed to the coronavirus and they have developed antibodies for the infection, government revealed on Tuesday.

Pre-existing coronavirus antibodies could help protect children against new pandemic strain: Study

Nov 09, 2020, at 01:13 am

London: Researchers at the Francis Crick Institute and University College London have found that some antibodies, created by the immune system during infection with common cold coronaviruses, can also target SARS-CoV-2 and may confer a degree of protection against the new viral strain.

Israeli researchers developing antibody cocktail to treat, prevent COVID-19

Oct 12, 2020, at 02:09 am

Jerusalem/Xinhua: Israeli researchers have been developing an antibody cocktail to treat and prevent COVID-19, Tel Aviv University (TAU) in central Israel said on Sunday.

Global coronavirus death toll crosses 2 lakhs, WHO says antibody response will provide some relief from reinfection

Apr 26, 2020, at 08:51 am

Geneva/IBNS: Hours after the World Health Organization claimed that recovery from coronavirus might not shield a person from reinfection, the global health body has clarified that people who are infected with COVID-19 will develop an antibody response that will provide some level of protection.

Human antibody discovery could save lives from fungal killer: Study

Dec 12, 2018, at 04:01 pm

London, Dec 12 (IBNS): A new way to diagnose, treat and protect against stealth fungal infections that claim more than 1.5 million lives per year worldwide has been moved a step closer, according to research published in Nature Communications.